Obesity and High-Fat Diet Induce Distinct Changes in Placental Gene Expression and Pregnancy Outcome

Endocrinology

Volumn 159, Issue 4, 2018, Pages 1718-1733

  Mahany, Erica B ^a   Han, Xingfa ^a,b   Borges, Beatriz C ^a,c   Da Silveira Cruz Machado, Sanseray ^a,c   Allen, Susan J ^a   Garcia Galiano, David ^a   Hoenerhoff, Mark J ^d   Bellefontaine, Nicole H ^a   Elias, Carol F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b SICHUAN AGRICULTURAL UNIVERSITY   (China)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN RECEPTOR; TRANSCRIPTOME; LEPTIN;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CONTROLLED STUDY; EMBRYO; EMBRYO RESORPTION; FAT INTAKE; FEMALE; FERTILITY; GENE EXPRESSION; INFLAMMATION; INFLAMMATORY INFILTRATE; LIPID DIET; MOUSE; NECROSIS; NONHUMAN; OBESITY; PHENOTYPE; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY OUTCOME; PRIORITY JOURNAL; SEX DIFFERENCE; SPONTANEOUS ABORTION; STILLBIRTH; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HYPOTHALAMUS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PREGNANCY; TRANSGENIC MOUSE;

ANIMALS; DIET, HIGH-FAT; FEMALE; GENE EXPRESSION REGULATION; HYPOTHALAMUS; INFLAMMATION; LEPTIN; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; OBESITY; PLACENTA; PREGNANCY; PREGNANCY OUTCOME; RECEPTORS, LEPTIN;

EID: 85044595674     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2017-03053     Document Type: Article

References (81)

1. Kopelman PG. Obesity as a medical problem. Nature. 2000; 404(6778):635-643.
2. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010; 303(3):235-241.
3. Salihu HM. Maternal obesity and stillbirth. Semin Perinatol. 2011; 35(6):340-344.
4. Racusin D, Stevens B, Campbell G, Aagaard KM. Obesity and the risk and detection of fetal malformations. Semin Perinatol. 2012; 36(3):213-221.
5. Aune D, Saugstad OD, Henriksen T, Tonstad S. Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and meta-analysis. JAMA. 2014;311(15): 1536-1546.
6. Persson M, Cnattingius S, Villamor E, Söderling J, Pasternak B, Stephansson O, Neovius M. Risk of major congenital malformations in relation to maternal overweight and obesity severity: cohort study of 1. 2 million singletons. BMJ. 2017;357:j2563.
7. Rankin J, Tennant PW, Stothard KJ, Bythell M, Summerbell CD, Bell R. Maternal body mass index and congenital anomaly risk: a cohort study [published corrigendumappears in Int J Obes. 2010; 34:1449]. Int J Obes. 2010;34(9):1371-1380.
8. Higgins L, Greenwood SL, Wareing M, Sibley CP, Mills TA. Obesity and the placenta: a consideration of nutrient exchange mechanisms in relation to aberrant fetal growth. Placenta. 2011; 32(1):1-7.
9. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860-867.
10. Challier JC, Basu S, Bintein T, Minium J, Hotmire K, Catalano PM, Hauguel-de Mouzon S. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta. 2008;29(3):274-281.
11. Aye IL, Lager S, Ramirez VI, Gaccioli F, Dudley DJ, Jansson T, Powell TL. Increasing maternal body mass index is associated with systemic inflammation in the mother and the activation of distinct placental inflammatory pathways. Biol Reprod. 2014;90(6):129.
12. Peraçoli JC, Rudge MV, Peraçoli MT. Tumor necrosis factor-alpha in gestation and puerperium of women with gestational hypertension and pre-eclampsia. Am J Reprod Immunol. 2007;57(3): 177-185.
13. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316(2):129-139.
14. Könner AC, Brüning JC. Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol Metab. 2011;22(1):16-23.
15. van der Burg JW, Allred EN, McElrath TF, Fichorova RN, Kuban K, O'Shea TM, Dammann O, Leviton A. Is maternal obesity associated with sustained inflammation in extremely low gestational age newborns? Early Hum Dev. 2013;89(12):949-955.
16. Frias AE, Morgan TK, Evans AE, Rasanen J, Oh KY, Thornburg KL, Grove KL. Maternal high-fat diet disturbs uteroplacental hemodynamics and increases the frequency of stillbirth in a nonhuman primate model of excess nutrition. Endocrinology. 2011: 152(6):2456-2464.
17. Carr DJ, David AL, Aitken RP, Milne JS, Borowicz PP, Wallace JM, Redmer DA. Placental vascularity and markers of angiogenesis in relation to prenatal growth status in overnourished adolescent ewes. Placenta. 2016;46:79-86.
18. Doshani A, Konje JC. Review: diabetes in pregnancy: insulin resistance, obesity and placental dysfunction. Br J Diabetes Vasc Dis. 2009;9(5):208-212.
19. Kebede MA, Attie AD. Insights into obesity and diabetes at the intersection of mouse and human genetics. Trends Endocrinol Metab. 2014;25(10):493-501.
20. Moley KH. Hyperglycemia and apoptosis: mechanisms for congenital malformations and pregnancy loss in diabetic women. Trends Endocrinol Metab. 2001;12(2):78-82.
21. Temple R, Aldridge V, Greenwood R, Heyburn P, Sampson M, Stanley K. Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study. BMJ. 2002;325(7375):1275-1276.
22. Dunne F, Brydon P, Smith K, Gee H. Pregnancy in women with type 2 diabetes: 12 years outcome data 1990-2002. Diabet Med. 2003; 20(9):734-738.
23. Arany E, Hill DJ. Fibroblast growth factor-2 and fibroblast growth factor receptor-1 mRNA expression and peptide localization in placentae from normal and diabetic pregnancies. Placenta. 1998; 19(2-3):133-142.
24. Jirkovsḱa M, Kubńová L, Jańacek J, Moravcová M, Krejć? V, Karen P. Topological properties and spatial organization of villous capillaries in normal and diabetic placentas. J Vasc Res. 2002; 39(3):268-278.
25. Barbour LA. Unresolved controversies in gestational diabetes: implications on maternal and infant health. Curr Opin Endocrinol Diabetes Obes. 2014;21(4):264-270.
26. Berglund ED, Vianna CR, Donato J Jr, Kim MH, Chuang JC, Lee CE, Lauzon DA, Lin P, Brule LJ, Scott MM, Coppari R, Elmquist JK. Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice. J Clin Invest. 2012; 122(3):1000-1009.
27. Borges BC, Garcia-Galiano D, da Silveira Cruz-Machado S, Han X, Gavrilina GB, Saunders TL, Auchus RJ, Hammoud SS, Smith GD, Elias CF. Obesity-induced infertility in male mice is associated with disruption of Crisp4 expression and sperm fertilization capacity. Endocrinology. 2017;158(9):2930-2943.
28. Fianco G, Mongiardi MP, Levi A, De Luca T, Desideri M, Trisciuoglio D, Del Bufalo D, Ciǹa I, Di Benedetto A, Mottolese M, Gentile A, Centonze D, Ferrè F, Barilà D. Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma. eLife. 2017;6:e22593.
29. Yuan D, Huang S, Berger E, Liu L, Gross N, Heinzmann F, Ringelhan M, Connor TO, Stadler M, Meister M, Weber J, Öllinger R, Simonavicius N, Reisinger F, Hartmann D, Meyer R, Reich M, Seehawer M, Leone V, Höchst B, Wohlleber D, Jörs S, Prinz M, Spalding D, Protzer U, Luedde T, Terracciano L, Matter M, Longerich T, Knolle P, Ried T, Keitel V, Geisler F, Unger K, Cinnamon E, Pikarsky E, Hüser N, Davis RJ, Tschaharganeh DF, Rad R,Weber A,Zender L,Haller D, Heikenwalder M. Kupffer cellderived Tnf triggers cholangiocellular tumorigenesis through JNK due to chronic mitochondrial dysfunction and ROS. Cancer Cell. 2017;31(6):771-789. e6.
30. Torsoni MA, Borges BC, Cote JL, Allen SJ, Mahany E, Garcia-Galiano D, Elias CF. AMPKa2 in Kiss1 neurons is required for reproductive adaptations to acute metabolic challenges in adult female mice. Endocrinology. 2016;157(12):4803-4816.
31. Cravo RM, Frazao R, Perello M, Osborne-Lawrence S, Williams KW, Zigman JM, Vianna C, Elias CF. Leptin signaling in Kiss1 neurons arises after pubertal development. PLoS One. 2013;8(3): e58698.
32. Scott MM, Lachey JL, Sternson SM, Lee CE, Elias CF, Friedman JM, Elmquist JK. Leptin targets in the mouse brain. J Comp Neurol. 2009;514(5):518-532.
33. Donato J Jr, Cravo RM, Frazao R, Gautron L, Scott MM,Lachey J, Castro IA, Margatho LO, Lee S, Lee C, Richardson JA, Friedman J, Chua S Jr, Coppari R, Zigman JM, Elmquist JK, Elias CF. Leptin's effect on puberty in mice is relayed by the ventral premammillary nucleus and does not require signaling in Kiss1 neurons. J Clin Invest. 2011;121(1):355-368.
34. McMinn JE, Liu SM, Dragatsis I, Dietrich P, Ludwig T, Eiden S, Chua SC Jr. An allelic series for the leptin receptor gene generated by CRE and FLP recombinase. Mamm Genome. 2004;15(9):677-685.
35. Allen SJ, Garcia-Galiano D, Borges BC, Burger LL, Boehm U, Elias CF. Leptin receptor null mice with reexpression of LepR in GnRHR expressing cells display elevated FSH levels but remain in a prepubertal state. Am J Physiol Regul Integr Comp Physiol. 2016: 310(11):R1258-R1266.
36. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M, Damsky CH. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest. 1997;99(9):2139-2151.
37. Larciprete G, Valensise H, Vasapollo B, Altomare F, Sorge R, Casalino B, De Lorenzo A, Arduini D. Body composition during normal pregnancy: reference ranges. Acta Diabetol. 2003; 40(Suppl 1): S225-S232.
38. Mouzon SH, Lassance L. Endocrine and metabolic adaptations to pregnancy; impact of obesity. Horm Mol Biol Clin Investig. 2015; 24(1):65-72.
39. Ryan D. Obesity in women: a life cycle of medical risk. Int J Obes. 2007;31::S3-S7.
40. Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr. 2010;91(1): 258S-261S.
41. Huda SS, Brodie LE, Sattar N. Obesity in pregnancy: prevalence and metabolic consequences. Semin Fetal Neonatal Med. 2010; 15(2):70-76.
42. Chavatte-Palmer P, Tarrade A, Rousseau-Ralliard D. Diet before and during pregnancy and offspring health: the importance of animal models and what can be learned from them. Int J Environ Res Public Health. 2016;13(6):586.
43. Saben J, Lindsey F, Zhong Y, Thakali K, Badger TM, Andres A, Gomez-AcevedoH, Shankar K. Maternal obesity is associatedwith a lipotoxic placental environment. Placenta. 2014;35(3):171-177.
44. Cnattingius S, Villamor E, Johansson S, Edstedt Bonamy AK, Persson M, Wikström AK, Granath F. Maternal obesity and risk of preterm delivery. JAMA. 2013;309(22):2362-2370.
45. Rossant J, Cross JC. Placental development: lessons from mouse mutants. Nat Rev Genet. 2001;2(7):538-548.
46. Knott JG, Paul S. Transcriptional regulators of the trophoblast lineage in mammals with hemochorial placentation. Reproduction. 2014;148(6):R121-R136.
47. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science. 1997; 277(5332):1669-1672.
48. Maltepe E, Simon MC. Oxygen, genes, and development: an analysis of the role of hypoxic gene regulation during murine vascular development. J Mol Med (Berl). 1998;76(6):391-401.
49. Carter AM. Animal models of human placentation-a review. Placenta. 2007;28(Suppl):S41-S47.
50. Chehab FF, Lim ME, Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet. 1996;12(3):318-320.
51. Mounzih K, Qiu J, Ewart-Toland A, Chehab FF. Leptin is not necessary for gestation and parturition but regulates maternal nutrition via a leptin resistance state. Endocrinology. 1998; 139(12):5259-5262.
52. Jansson N, Greenwood SL, Johansson BR, Powell TL, Jansson T. Leptin stimulates the activity of the systemAamino acid transporter in human placental villous fragments. J Clin Endocrinol Metab. 2003;88(3):1205-1211.
53. Henson MC, Castracane VD. Leptin in pregnancy: an update. Biol Reprod. 2006;74(2):218-229.
54. Jones HN, Woollett LA, Barbour N, Prasad PD, Powell TL, Jansson T. High-fat diet before and during pregnancy causes marked upregulation of placental nutrient transport and fetal overgrowth in C57/BL6 mice. FASEB J. 2009;23(1):271-278.
55. Farley DM, Choi J, Dudley DJ, Li C, Jenkins SL, Myatt L, Nathanielsz PW. Placental amino acid transport and placental leptin resistance in pregnancies complicated by maternal obesity. Placenta. 2010;31(8):718-724.
56. McCarthy JF, Misra DN, Roberts JM. Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration. Am J Obstet Gynecol. 1999;180(3):731-736.
57. Hauguel-de Mouzon S, Lepercq J, Catalano P. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol. 2006; 194(6):1537-1545.
58. Tessier DR, Ferraro ZM, Gruslin A. Role of leptin in pregnancy: consequences of maternal obesity. Placenta. 2013;34(3):205-211.
59. Spradley FT, Palei AC, Granger JP. Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms. Am J Physiol Regul Integr Comp Physiol. 2015; 309(11):R1326-R1343.
60. Kristensen J, Vestergaard M, Wisborg K, Kesmodel U, Secher NJ. Pre-pregnancy weight and the risk of stillbirth and neonatal death. BJOG. 2005;112(4):403-408.
61. Pereza N, Ostojic S, Kapovic M, Peterlin B. Systematic review and meta-analysis of genetic association studies in idiopathic recurrent spontaneous abortion. Fertil Steril. 2017;107(1): 150-159. e2.
62. Xu X, Du C, Li H, Du J, Yan X, Peng L, Li G, Chen ZJ. Association of VEGF genetic polymorphisms with recurrent spontaneous abortion risk: a systematic review and meta-analysis. PLoS One. 2015;10(4):e0123696.
63. Goksu Erol AY, Nazli M, Elis Yildiz S. Significance of platelet endothelial cell adhesion molecule-1 (PECAM-1) and intercellular adhesion molecule-1 (ICAM-1) expressions in preeclamptic placentae. Endocrine. 2012;42(1):125-131.
64. Nakada E, Walley KR, Nakada T, Hu Y, von Dadelszen P, Boyd JH. Toll-like receptor-3 stimulation upregulates sFLT-1 production by trophoblast cells. Placenta. 2009;30(9):774-779.
65. Taylor BD, Tang G, Ness RB, Olsen J, Hougaard DM, Skogstrand K, Roberts JM, Haggerty CL. Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls. Pregnancy Hypertens. 2016;6(1):72-78.
66. Simonds SE, Pryor JT, Ravussin E, Greenway FL, Dileone R, Allen AM, Bassi J, Elmquist JK, Keogh JM, Henning E, Myers MG Jr, Licinio J, Brown RD, Enriori PJ, O'Rahilly S, Sternson SM, Grove KL, Spanswick DC, Farooqi IS, Cowley MA. Leptin mediates the increase in blood pressure associated with obesity. Cell. 2014; 159(6):1404-1416.
67. Rosario FJ, Powell TL, Jansson T. Activation of placental insulin and mTOR signaling in a mouse model of maternal obesity associated with fetal overgrowth. Am J Physiol Regul Integr Comp Physiol. 2016;310(1):R87-R93.
68. Shi H, Seeley RJ, Clegg DJ. Sexual differences in the control of energy homeostasis. Front Neuroendocrinol. 2009;30(3):396-404.
69. Aye ILMH, Gao X, Weintraub ST, Jansson T, Powell TL. Adiponectin inhibits insulin function in primary trophoblasts by PPARa-mediated ceramide synthesis. Mol Endocrinol. 2014;28(4): 512-524.
70. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR,GuW,Kesterson RA, Boston BA,Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997;88(1):131-141.
71. Vaisse C, Clement K, Guy-Grand B, Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet. 1998;20(2):113-114.
72. Yeo GS, Farooqi IS, Aminian S,Halsall DJ, Stanhope RG, O'Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet. 1998;20(2):111-112.
73. Spradley FT, Palei AC, Granger JP. Obese melanocortin-4 receptordeficient rats exhibit augmented angiogenic balance and vasorelaxation during pregnancy. Physiol Rep. 2013;1(4):e00081.
74. Salimi S, Yaghmaei M, Tabatabaei E, Mokhtari M, Naghavi A. Vascular endothelial growth factor (VEGF)-634G/C polymorphism was associated with severe pre-eclampsia and lower serum VEGF level. J Obstet Gynaecol Res. 2015;41(12): 1877-1883.
75. Galbiati S, Inversetti A, Causarano V, Stenirri S, Soriani N, Ambrosi A, Valsecchi L, Candiani M, Cremonesi L, Ferrari M, Smid M. HIF1A and MIF as potential predictivemRNAbiomarkers of pre-eclampsia: a longitudinal prospective study in high risk population. Clin Chem Lab Med. 2015;53(9):1339-1347.
76. Zhao M, Zhu Z, Liu C, Zhang Z. Dual-cutoff of sFlt-1/PlGF ratio in the stratification of preeclampsia: a systematic review and metaanalysis. Arch Gynecol Obstet. 2017;295(5):1079-1087.
77. Kaartokallio T, Cervera A, Kyllönen A, Laivuori K, Kere J, Laivuori H, Group FCI; FINNPEC Core Investigator Group. Corrigendum: Gene expression profiling of pre-eclamptic placentae by RNA sequencing. Sci Rep. 2016;6(1):17245.
78. Simsek Y, Gul M, Celik O, Aydin NE, Arda Düz S, Celik E, Ozerol E, Özerol IH, Tanbek K. Nuclear transcription factor-kappa betadependent ultrastructural alterations within the placenta and systemic inflammatory activation in pregnant patients with hemolysis, elevated liver functions and low thrombocyte count (HELLP) syndrome: a case-control study. Hypertens Pregnancy. 2013;32(3): 281-291.
79. Vaughan JE, Walsh SW. Activation of NF-kB in placentas of women with preeclampsia. Hypertens Pregnancy. 2012;31(2): 243-251.
80. Chatterjee P, Weaver LE, Doersch KM, Kopriva SE, Chiasson VL, Allen SJ, Narayanan AM, Young KJ, Jones KA, Kuehl TJ, Mitchell BM. Placental Toll-like receptor 3 and Toll-like receptor 7/8 activation contributes to preeclampsia in humans and mice. PLoS One. 2012;7(7):e41884.
81. Li P, Wu HL, Dong BH. Relationship between TLR4 and CCL2 expression and recurrent spontaneous abortion. Genet Mol Res. 2016;15(1):1-8.